Toronto Dominion Bank grew its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 41.6% during the first quarter, Holdings Channel reports. The institutional investor owned 710,056 shares of the pharmacy operator’s stock after purchasing an additional 208,607 shares during the quarter. Toronto Dominion Bank’s holdings in Walgreens Boots Alliance were worth $44,914,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Horan Capital Advisors LLC. purchased a new stake in Walgreens Boots Alliance in the first quarter worth about $25,000. Massey Quick Simon & CO. LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth about $27,000. Murphy Pohlad Asset Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth about $29,000. PRW Wealth Management LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth about $34,000. Finally, Nalls Sherbakoff Group LLC purchased a new stake in Walgreens Boots Alliance in the fourth quarter worth about $42,000. 64.77% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages have commented on WBA. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Thursday, February 14th. UBS Group began coverage on shares of Walgreens Boots Alliance in a report on Thursday, January 17th. They issued a “sell” rating and a $70.00 price objective for the company. Loop Capital set a $82.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Wednesday, January 23rd. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, February 26th. Finally, Robert W. Baird lowered their price objective on shares of Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating for the company in a report on Friday, March 1st. Five equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $68.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.70 by ($0.06). Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The business had revenue of $34.53 billion for the quarter, compared to the consensus estimate of $34.57 billion. During the same period in the prior year, the business posted $1.73 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, analysts forecast that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.32%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
In other news, COO Ornella Barra purchased 18,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, April 3rd. The stock was bought at an average price of $54.56 per share, with a total value of $982,080.00. Following the completion of the transaction, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at $1,441,748. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total transaction of $1,061,000.00. Following the sale, the chief accounting officer now directly owns 435,811 shares of the company’s stock, valued at approximately $23,119,773.55. The disclosure for this sale can be found here. 15.73% of the stock is currently owned by company insiders.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Net Margin
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.